Plain-English translation of NCT07178639 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After cataract surgery, some patients develop swelling in a part of the eye called the macula, which can affect vision. This trial is testing three different anti-inflammatory eye drops—bromfenac 0.09%, nepafenac 0.3%, and diclofenac 0.1%—to find out which one is most effective at preventing or reducing this swelling. Researchers want to learn which medication works best and causes the fewest side effects.
Swelling in the retina after cataract surgery is a common problem that can blur vision and slow recovery. Doctors currently use several different anti-inflammatory drops, but no one knows which one works best. This trial will help doctors choose the most effective treatment for their patients.
You likely qualify if…
You likely don't qualify if…
You will receive one of the three eye drop treatments starting 4 days before your cataract surgery and continuing for 21 days after surgery. Depending on which drop you receive, you will apply it either once, twice, or four times daily to your eye. You will visit the clinic on day 1 after surgery, then at 1 week, 3 weeks, and 6 weeks, where doctors will examine your eye with a special imaging machine (OCT), check your vision, and ask about your recovery and quality of life.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Czechia